Staying Smaller and Tighter With This GoodRx Trade

I'm focusing on the active consumers and subscription plans as it gives us a view of the future.

Does Cardiff Oncology Pass the Speculative Test?

After watching the moves in Trillium Therapeutics, a Real Money reader wants to play CRDF. Here's the what the charts say.

Taiwan Administers First Home-Made Vaccine

Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.

Jim Cramer: What's With the Waffling in the Market?

I think it's all about peak Delta or lack thereof.

Cramer Says 'Buy' for Intuitive Surgical, but What Do the Charts Say?

Let's see if his intuition is right on ISRG.

Cramer Says Doximity Has Right Prescription, and the Charts Agree

We don't have a lot of price history, but what we do see is bullish for DOCS.

Ventas Looks Stagnant for Now But Could See Shares Rise Later This Year

The technical signs of the provider of senior housing are mixed at present.

3 Healthcare Stocks for 3%+ Dividend Yields

These picks are attractive for value-oriented dividend investors looking for strong current income potential.

For Now, Moderna Is an Options Play For Me

The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.

Moderna Flashes Signs of an Interim Top

The charts of the vaccine maker indicate it's a good time to take some profits or raise stops, or both.